MedPath

Euclises Pharmaceuticals, Inc.

Euclises Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2011-10-01
Employees
1
Market Cap
-
Website
http://www.euclises.com

ECP-1014 Treatment for Patients With Solid Tumor Cancers

Phase 1
Recruiting
Conditions
Solid Tumor
Interventions
First Posted Date
2021-06-18
Last Posted Date
2023-02-16
Lead Sponsor
Euclises Pharmaceuticals, Inc.
Target Recruit Count
29
Registration Number
NCT04930354
Locations
🇨🇳

The Sixth Affiliated Hospital Sun Yat-sen University, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath